HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, China

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborator:
Comprehensive International Program of Research on AIDS
Information provided by:
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00068991
First received: September 12, 2003
Last updated: February 17, 2009
Last verified: September 2008

September 12, 2003
February 17, 2009
Not Provided
Not Provided
Medical Outcomes Study HIV Health Survey (MOS-HIV) score in-HIV infected participants [ Time Frame: Throughout study ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT00068991 on ClinicalTrials.gov Archive Site
  • Level of stigma among community members, as determined by HIV knowledge score and HIV attitudes and stigmatizing behaviors reported [ Time Frame: Throughout study ] [ Designated as safety issue: No ]
  • Emotional well-being of HIV-infected participants, as determined by perceived support scale and stigma scale scores [ Time Frame: Throughout study ] [ Designated as safety issue: No ]
  • Self-efficacy score in HIV-infected participants [ Time Frame: Throughout study ] [ Designated as safety issue: No ]
  • Knowledge of correct condom use score among HIV-infected participants [ Time Frame: Throughout study ] [ Designated as safety issue: No ]
Not Provided
Not Provided
Not Provided
 
HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, China
A Cluster-Randomized Trial to Evaluate the Efficacy of a Combined Individual- and Community-Based Behavioral Intervention to Improve Quality of Life for HIV-Positive Villagers in Rural China (China CIPRA Project 2)

The purpose of this study is to determine whether two educational programs about HIV will improve the quality of life of HIV infected people living in the rural villages of China. The study will enroll HIV infected adult residents, influential community members, and other community members of selected villages of Funan County or Yingzhou District, Anhui Province, China.

A previous study found that HIV-infected villagers in Anhui Province, China describe their quality of life as poor. While poverty, poor health, stigma, and discrimination contribute to this poor quality of life, all these issues are interrelated and deserve further investigation. The quality of life for HIV-infected people may be made better through education, either for HIV-infected people to learn more about HIV, the treatments they are receiving, and how to deal with their disease, or for HIV uninfected people to understand HIV infection and to reduce stigma and discrimination associated with HIV infection. This study will provide skills training to HIV-infected adults and anti-stigma and anti-discrimination training to influential community members. The purpose of this study is to evaluate the changes in quality of life in HIV-infected villagers living in Anhui Province, China that result after these two training programs are administered.

There will be 3 groups in this study. Group 1 participants will be HIV-infected villagers. Group 1 participants will take part in 2-hour skills training sessions every week from study entry to Week 8. Participants will also be asked to bring a family member to each training session. After completing training, participants will be asked to complete a post-training evaluation of the training sessions. Group 1 participants will be asked to complete questionnaires at study entry and 6 and 12 months after completion of training.

Group 2 participants will be villagers considered influential members of their community. In the first 2 months of the study, Group 2 participants will take part in four, 2-hour training sessions focusing on anti-stigma and anti-discrimination messages. Group 2 participants will also attend additional support meetings monthly, from Months 2 to 15. Group 2 participants will be evaluated before and after their training sessions to determine the improvements in knowledge and attitudes about HIV among group participants.

Group 3 participants will be randomly selected community members and will complete a cross-sectional survey at study entry and 6 and 12 months after Group 2's completion of training, to determine changing community attitudes about HIV as a result of Group 2's training. There will be no additional study visits or training for Group 3 participants.

Interventional
Phase 1
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
HIV Infections
  • Behavioral: HIV skills training program and questionnaire
    Two-hour weekly skills training sessions followed by evaluation questionnaire
  • Behavioral: Community-level stigma reduction program
    Two-hour training sessions focusing on anti-stigma and anti-discrimination
  • Behavioral: Cross-sectional survey
    Survey evaluation of community attitudes towards HIV
  • Experimental: 1
    Participants will be HIV-infected villagers and will will take part in 2-hour skills training sessions every week from study entry to Week 8. Participants will bring a family member to each training session. After training, participants complete a post-training evaluation of the training sessions. Participants will also complete questionnaires at study entry and 6 and 12 months after completion of training.
    Intervention: Behavioral: HIV skills training program and questionnaire
  • Experimental: 2
    Participants will be villagers considered influential members of their community. In the first 2 months of the study, Participants will take part in four 2-hour training sessions focusing on anti-stigma and anti-discrimination messages. Participants will also attend additional support meetings monthly, from Months 2 to 15. They will be evaluated before and after their training sessions to determine the improvements in knowledge and attitudes about HIV among group participants.
    Intervention: Behavioral: Community-level stigma reduction program
  • Experimental: 3
    Participants will be randomly selected community members and will complete a cross-sectional survey at study entry and 6 and 12 months after Group 2's completion of training to determine changing community attitudes about HIV as a result of Group 2's training. There will be no additional study visits or training for Group 3 participants.
    Intervention: Behavioral: Cross-sectional survey
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
3830
June 2007
Not Provided

Inclusion Criteria for All Participants:

  • Live in one of the fourteen administrative villages in Funan County or Yingzhou District, Anhui Province, China

Inclusion Criteria for Group 1:

  • HIV-infected
  • Willing and able to take part in all study visits
  • Willing and able to provide contact information for locator purposes
  • Willing and able to bring a family member to training sessions

Inclusion Criteria for Group 2:

  • Considered an influential member of their community
  • Willing and able to take part in all training and follow-up support meetings

Inclusion Criteria for Group 3:

  • Willing to complete the cross-sectional survey

Exclusion Criteria for All Study Participants:

  • Spent more than 6 months outside of the community in the year prior to study entry
  • Permanent disability (e.g., deafness, serious mental illness, mental retardation) that would interfere with the study
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
China
 
NCT00068991
CIPRA Project 2, 1U19-AI51915-01, CIPRA CH 002
No
Rona Siskind, DAIDS
National Institute of Allergy and Infectious Diseases (NIAID)
Comprehensive International Program of Research on AIDS
Principal Investigator: Zunyou Wu, MD, PhD Chinese Center for Disease Control and Prevention
Principal Investigator: Jie Xu, MD, MS Chinese Center for Disease Control and Prevention
National Institute of Allergy and Infectious Diseases (NIAID)
September 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP